General Biologicals Corporation
4117.TWO
Taipei Exchange10.10
TWD
-0.20
- -
Total Valuation
General Biologicals Corporation carries a market capitalization of 604.22M, placing it among publicly traded companies globally.
| Market Cap | 604.22M |
| Enterprise Value | N/A |
Stock Price Statistics
General Biologicals Corporation's stock has declined approximately -35.25641% over the past 52 weeks. The 50-day moving average sits at 6.65, while the 200-day moving average is 10.11.
| Beta (5Y) | N/A |
| 52-Week Price Change | -35.25641% |
| 50-Day Moving Average | 6.65 |
| 200-Day Moving Average | 10.11 |
| Average Volume (20 Days) | N/A |
Stock Splits
General Biologicals Corporation's most recent stock split took place on September 8, 2025 with a 500:517 split ratio.
| Last Split Date | 9/8/2025 |
| Split Ratio | 500:517 |